Abstract

Mutations in TDP-43 are associated with proteinaceous inclusions in neurons and are believed to be causative in neurodegenerative diseases such as frontotemporal dementia or amyotrophic lateral sclerosis. Here we describe a Drosophila system where we have engineered the genome to replace the endogenous TDP-43 orthologue with wild type or mutant human TDP-43(hTDP-43). In contrast to other models, these flies express both mutant and wild type hTDP-43 at similar levels to those of the endogenous gene and importantly, no age-related TDP-43 accumulation observed among all the transgenic fly lines. Immunoprecipitation of TDP-43 showed that flies with hTDP-43 mutations had increased levels of ubiquitination and phosphorylation of the hTDP-43 protein. Furthermore, histologically, flies expressing hTDP-43 M337V showed global, robust neuronal staining for phospho-TDP. All three lines: wild type hTDP-43, -G294A and -M337V were homozygous viable, with no defects in development, life span or behaviors observed. The primary behavioral defect was that flies expressing either hTDP-43 G294A or M337V showed a faster decline with age in negative geotaxis. Together, these observations implied that neurons could handle these TDP-43 mutations by phosphorylation- and ubiquitin-dependent proteasome systems, even in a background without the wild type TDP-43. Our findings suggest that these two specific TDP-43 mutations are not inherently toxic, but may require additional environmental or genetic factors to affect longevity or survival.

Highlights

  • Cytoplasmic protein aggregates are a common pathological feature of many neurodegenerative diseases [1]

  • To minimize the effects of over-expression, we have developed an alternative method of expressing human TDP-43 (hTDP-43) cDNA under the control of the endogenous TBPH regulatory regions in the absence of endogenous TBPH expression, using the CRISPR/Cas9 genome editing technique (Fig 1A)

  • These results showed that there were no differences in expression between flies expressing TBPH and wild type hTDP-43 with or without the DsRed cassette (Fig 1B)

Read more

Summary

Methods

The following fly strains were obtained from the Bloomington stock center (http://flystocks.bio.indiana.edu/): y[1] M{vas-Cas.RFP-}ZH-2A w[1118] was the parental line used for CRISPR/Cas injections and y[1] w[67c23] P{y[+mDint2] = Crey}1b; sna[Sco]/CyO carrying the Cre recombinase was used to remove the DsRed cassette in the transgenic flies. One plasmid contained a donor template coding for the hTDP-43 cDNA sequence and a red fluorescent protein under the control of an eye-specific promoter flanked by portions of the TBPH 3’ and 5’ UTR was injected at a concentration of 500 ng/μl, and the other contained two guide RNAs and injected at a concentration of 200 ng/μl. The guide RNAs target cas to sites on either side of the TBPD coding region, resulting in two double strand breaks which are repaired by homologous recombination using the donor template

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call